BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang CR, Tsai HW. Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. World J Diabetes 2021; 12(3): 238-260 [PMID: PMC7958474 DOI: 10.4239/wjd.v12.i3.238]
URL: https://www.wjgnet.com/1948-9358/full/v12/i3/238.htm
Number Citing Articles
1
Zeinab Vafaeipour, Mahboobeh Ghasemzadeh Rahbardar, Hossein Hosseinzadeh. Effect of saffron, black seed, and their main constituents on inflammatory cytokine response (mainly TNF-α) and oxidative stress status: an aspect on pharmacological insightsNaunyn-Schmiedeberg's Archives of Pharmacology 2023; 396(10): 2241 doi: 10.1007/s00210-023-02501-w
2
Annika Smith, Aidin Karahasan, Deborah Yi, Sanjay Yapabandara, James Elhindi, Pablo Fernandez-Penas, Clara Chow, Sarah Zaman. Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective ReviewDermatology and Therapy 2025; 15(1): 201 doi: 10.1007/s13555-024-01327-5
3
Yu Zhou, Wenhuo Xie, Linyao Wang, Xinyan Zhu, Jianbin Li, Libin Liu, Shuaijun Zhu, Lijing Wang. Anti-tumor Necrosis Factor-Alpha Therapy and Hypoglycemia: A Real-World Pharmacovigilance AnalysisDrug Safety 2022; 45(9): 951 doi: 10.1007/s40264-022-01210-2
4
Jun Shu, Nan Li, Wenshi Wei, Li Zhang. Detection of molecular signatures and pathways shared by Alzheimer’s disease and type 2 diabetesGene 2022; 810: 146070 doi: 10.1016/j.gene.2021.146070
5
Fabrizio Cantini, Delia Goletti, Maurizio Benucci, Rosario Foti, Arianna Damiani, Laura Niccoli. Tailored first-line biologic and targeted synthetic disease modifying anti-rheumatic drugs therapy in patients with rheumatoid arthritis: 2021 updated ITABIO statementsExpert Opinion on Drug Safety 2022; 21(5): 613 doi: 10.1080/14740338.2022.2020247
6
Zheng Ren, Liang He, Jing Wang, Li Shu, Chenyang Li, Yuan Ma. The harmful effect of ankylosing spondylitis on diabetes mellitus: new evidence from the Mendelian randomization analysisFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1369466
7
Emmanuelle Rochette, Oussama Saidi, Étienne Merlin, Pascale Duché. Physical activity as a promising alternative for young people with juvenile idiopathic arthritis: Towards an evidence-based prescriptionFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1119930
8
Qian Zhang, Du Jin, Xiaoyue Mou, Hengli Ye. PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitisJournal of Clinical Laboratory Analysis 2022; 36(3) doi: 10.1002/jcla.24267
9
Song-Chou Hsieh, Ping-Han Tsai, Chang-Fu Kuo, Tien-Tsai Cheng, Ning-Sheng Lai, Jing-Chi Lin, Liang-Hung Lin, Chang-Youh Tsai. Health-related quality of life improvement by adalimumab therapy in patients with rheumatoid arthritis in Taiwan: A nationwide prospective studyJournal of the Chinese Medical Association 2023; 86(4): 366 doi: 10.1097/JCMA.0000000000000889
10
Di Wu, Yehao Luo, Tong Li, Xinyi Zhao, Ting Lv, Gang Fang, Peiqi Ou, Hongyi Li, Xiaofan Luo, An Huang, Yuzhou Pang. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatmentFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1051082
11
Ignacio Marín-Jiménez, Daniel Carpio, Vicent Hernández, Fernando Muñoz, Eduardo Zatarain-Nicolás, Yamile Zabana, Míriam Mañosa, Francisco Rodríguez-Moranta, Manuel Barreiro-de Acosta, Ana Gutiérrez Casbas. Documento de posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la enfermedad cardiovascular en los pacientes con enfermedad inflamatoria intestinalGastroenterología y Hepatología 2024; : 502314 doi: 10.1016/j.gastrohep.2024.502314
12
Chrong-Reen Wang, Hung-Wen Tsai. Autoimmune liver diseases in systemic rheumatic diseasesWorld Journal of Gastroenterology 2022; 28(23): 2527-2545 doi: 10.3748/wjg.v28.i23.2527
13
Jing Li, Yazhuo Chen, Qingyun Liu, Zhufang Tian, Yan Zhang. Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitusClinical and Experimental Medicine 2022; 23(2): 287 doi: 10.1007/s10238-022-00816-1
14
Chrong-Reen Wang, Hung-Wen Tsai. Immediate-release tofacitinib reduces insulin resistance in non-diabetic active rheumatoid arthritis patients: A single-center retrospective studyWorld Journal of Diabetes 2022; 13(6): 454-465 doi: 10.4239/wjd.v13.i6.454
15
Yuliya Fedorchenko, Khaiyom Mahmudov, Zhumabek Abenov, Olena Zimba, Marlen Yessirkepov. Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerationsRheumatology International 2023; 43(12): 2167 doi: 10.1007/s00296-023-05453-9